Trends in deaths involving melanoma and cardiovascular disease among older US adults from 1999 to 2020
Malignant melanoma (MM) is an aggressive skin cancer with rising incidence and improved survival. However, trends in U.S. deaths involving both MM and cardiovascular disease (CVD) among older adults are not well characterized. We aimed to describe age-adjusted mortality trends and disparities for these deaths among U.S. adults aged 65 years or older from 1999 to 2020. We used the CDC WONDER Multiple Cause of Death database to assess US mortality trends from 1999 to 2020 among adults aged 65 years or older whose death certificates listed MM (ICD-10 C43) and CVD (ICD-10 I00–I99) as underlying or contributing causes. We calculated age-adjusted mortality rates (AAMRs) per 100,000 and annual percent changes (APCs) using Joinpoint regression, with results stratified by sex, race, place of death, region, state, and metropolitan status. This analysis describes deaths involving both conditions in the population; it does not estimate cardiovascular mortality risk among patients with melanoma. Between 1999 and 2020, 39,190 deaths involving MM and CVD were recorded among adults aged 65 years or older, 36.8% at home. AAMR increased from 3.8 to 5.0 (APC 0.95%, 95% CI 0.64 to 1.31). Men had higher AAMRs than women (7.0 vs. 2.5). AAMRs were highest in NH Whites (5.0), followed by Hispanics (1.3), and lowest in NH Blacks (0.8). Final-segment APCs were 10.38% for nonmetropolitan counties (2018–2020) and 3.44% for metropolitan counties (2016–2020); these segments are not directly comparable. AAMRs across states ranged from 1.4 (District of Columbia) to 6.1 (California, Oklahoma, Nebraska), with overlapping CIs. The West had the highest regional AAMR (5.1). The rate of deaths in which both MM and CVD were listed as underlying or contributing causes is rising among older adults, with notable disparities by sex, race, and geography, highlighting the need for targeted, region-specific interventions to reduce this burden.
Authors
- Waseem Sajjad (ORCID: https://orcid.org/0000-0002-6650-9366)
- Ihsan Qamar (ORCID: https://orcid.org/0009-0002-6491-1404)
- Danish Ali Ashraf (ORCID: https://orcid.org/0000-0002-3013-9359)
- Shahzaib M. Khan (ORCID: https://orcid.org/0009-0009-0547-9296)
- Fatima Najam (ORCID: https://orcid.org/0009-0003-7825-4537)
- Mahnoor Khan (ORCID: https://orcid.org/0009-0009-8028-6814)
- Zauha Fawad Memon (ORCID: https://orcid.org/0009-0007-3422-7632)
- Muhammad Mughees (ORCID: https://orcid.org/0009-0008-3511-8777)
- Sameer Ehtesham (ORCID: https://orcid.org/0009-0000-2285-841X)
- Saqlain Anwar (ORCID: https://orcid.org/0009-0006-9707-9588)
- Amna Rizwan Bhatti
- Rawdah Shakil
- Saad Hassan Qureshi (ORCID: https://orcid.org/0009-0009-8562-5491)
Institutions
- King Edward Medical University (PK)
- Foundation University Medical College (PK)
- Community Medical Center (US)
- Abington Memorial Hospital (US)
- Dow University of Health Sciences (PK)
- Spinghar Institute of Higher Education, Kabul (AF)
- People's University of Medical and Health Sciences for Women (PK)
- Bahria University (PK)
- Ziauddin University (PK)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41598-026-79090-0
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00